What role do brain lipids play in Parkinson’s disease?

New research looks to brain lipids to identify a new therapeutic target for Parkinson’s disease.

Parkinson’s disease is a neurodegenerative condition that affects about half a million people in the United States, according to the National Institutes of Health.

One of the main characteristics of this condition is the buildup of alpha-synuclein, a type of protein that forms into toxic plaques, in the brain.

Earlier this year, a study that featured in the journal Neurobiology of Aging suggested that there may be a link between the levels of certain brain lipids, or fat molecules, and the development of Parkinson’s disease.

Full story at Medical News Today